Fred Alger Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Fred Alger Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-167,415	Closed	-$3.57M	–	483
2024 Q1	$3.57M	Sell	167,415 -144,559	-46%	-$1.73M	0.02%	286
2023 Q4	$3M	Buy	+311,974	New	+$1.52M	0.02%	293

Fred Alger Management's FUSN Position: Q2 2024 in Review

Fred Alger Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 167,415 shares — an estimated $3.57M sold.

Fred Alger Management first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $3.57M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Fred Alger Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Fred Alger Management sold 167,415 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.57M.
Fred Alger Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Fred Alger Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.57M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.